title: Angiomyofibroblastoma of the vagina in a breast cancer patient.
authors.forename: Ho
authors.initials: H
authors.lastname: Lee
authors.forename: Kyu-Yun
authors.initials: KY
authors.lastname: Jang
authors.forename: Ho-Sung
authors.initials: HS
authors.lastname: Park
authors.forename: Sung-Ho
authors.initials: SH
authors.lastname: Hwang
authors.forename: Shin-Young
authors.initials: SY
authors.lastname: Park
authors.forename: Keum-Ha
authors.initials: KH
authors.lastname: Choi
authors.forename: Jong-Hyun
authors.initials: JH
authors.lastname: Kim
authors.forename: Woo-Sung
authors.initials: WS
authors.lastname: Moon
mesh_terms: D018322:Angiofibroma / Q000378:metabolism / Q000473:pathology*; D018229:Angiomyoma / Q000378:metabolism / Q000473:pathology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016609:Neoplasms, Second Primary / Q000378:metabolism / Q000473:pathology*; D011960:Receptors, Estrogen / Q000096:biosynthesis; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D017312:Toremifene / Q000627:therapeutic use; D014625:Vaginal Neoplasms / Q000378:metabolism / Q000473:pathology*
chemical_list: D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D017312:Toremifene; D004317:Doxorubicin; D003520:Cyclophosphamide